Harvey-Bradshaw Index (HBI) for Crohn's Disease
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۵۰
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Remission0–4
- Mild Disease5–7
- Moderate Disease8–16
- Severe Disease17–100
The Harvey-Bradshaw Index (HBI) for Crohn's Disease calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include general wellbeing. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.
Clinical Indication
The Harvey-Bradshaw Index (HBI) for Crohn's Disease is indicated for bedside clinical practice to support Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: A reduction of 3 points is considered clinically significant response to treatment.
HBI Score = General well-being (0-4) + Abdominal pain (0-3) + Number of liquid stools (1 point per stool) + Abdominal mass (0-3) + Complications (1 point each)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| general_wellbeing | integer | Yes | General well-being (assessed for the previous day) |
| abdominal_pain | integer | Yes | Abdominal pain (assessed for the previous day) |
| liquid_stools | integer | Yes | Number of liquid or soft stools per day (assessed for the previous day) |
| abdominal_mass | integer | Yes | Abdominal mass on examination |
| complications | array | Yes | Extra-intestinal manifestations (1 point each) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Remission | Disease in remission |
| 5–7 | Mild Disease | Mild disease activity |
| 8–16 | Moderate Disease | Moderate disease activity |
| 17–100 | Severe Disease | Severe disease activity |
Evidence-Based References (EBM)
- Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.DOI: 10.1016/s0140-6736(80)92767-1
- Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clin Gastroenterol Hepatol. 2016 Mar;14(3):348-354.e17. doi: 10.1016/j.cgh.2015.06.001.DOI: 10.1016/j.cgh.2015.06.001
- Gomes P, du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986 Jan;27(1):92-5. doi: 10.1136/gut.27.1.92.DOI: 10.1136/gut.27.1.92